Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Rosanna Squitti
 + 4320 word(s) 4320 2021-06-10 05:54:56 |
2 format correct
Vivi Li
 Meta information modification 4320 2021-06-22 08:24:37 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Squitti, R. Copper and Alzheimer’s Disease. Encyclopedia. Available online: https://encyclopedia.pub/entry/11088 (accessed on 04 December 2024).
Squitti R. Copper and Alzheimer’s Disease. Encyclopedia. Available at: https://encyclopedia.pub/entry/11088. Accessed December 04, 2024.
Squitti, Rosanna. "Copper and Alzheimer’s Disease" Encyclopedia, https://encyclopedia.pub/entry/11088 (accessed December 04, 2024).
Squitti, R. (2021, June 21). Copper and Alzheimer’s Disease. In Encyclopedia. https://encyclopedia.pub/entry/11088
Squitti, Rosanna. "Copper and Alzheimer’s Disease." Encyclopedia. Web. 21 June, 2021.
Copper and Alzheimer’s Disease
Edit
This entry is adapted from the peer-reviewed paper 10.3390/biom10060897

Copper is an essential nutrient for plants, animals, and humans because it is an indispensable component of several essential proteins and either lack or excess are harmful to human health. Recent studies revealed that the breakdown of the regulation of copper homeostasis could be associated with Alzheimer’s disease (AD), the most common form of dementia. Copper imbalance occurs in human aging and is thought to increase the risk of AD for individuals with susceptibility to copper exposure. The main feature of Cu imbalance in AD consists in the increase of a Cu species of the metal nonbound to proteins, called non-ceruloplasmin Cu (also known as ‘free Cu’) that is highly reactive. Non-ceruloplasmin Cu is a small molecular weight Cu that is exchanged among albumin and other serum proteins, peptides, and amino acids. It is an established marker of Wilson disease, the paradigmatic disease on Cu toxicosis or accumulation, but it increases also in AD. When exceeding 1.6 micromolar in serum, non-ceruloplasmin Cu is toxic and can cross the blood brain barrier and reach the brain, reacting with other drivers of AD, as for example the beta amyloid (Aβ), the main constituent of the amyloid plaques 

heavy metal dementia organic agriculture agroecology

1. Alzheimer’s Disease and Copper

Copper is an essential trace metal controlling human physiology. Brain cells use copper during development, and it is indispensable in vital processes such as respiration, energy production, formation of the myelin sheath around neurons, synthesis of neurotransmitters, immune system responses, collagen and pigment synthesis, and wound healings. We surveyed the number of papers in the medicine database on the biological connection between AD and copper. The search on ‘Scopus’ with the terms “Alzheimer’s disease and copper” provided 3009 document results (Figure 1).
Biomolecules 10 00897 g001 550
Figure 1. Pie chart illustrating the literature published on the topic ‘Copper’ and “Alzheimer’s disease”. Search on the Scopus research engine retrieved 3009 scientific articles; the stratification by ‘subject area’ reveals that 25.7% of the papers published come from the Biochemistry area, 17.3% from Medicine, 15.8% from Neuroscience, 12.7% from Chemistry, and 9.2% from Pharmacology.
The stratification by ‘subject area’ of the Scientific Journals of publication can help depict the large areas of scientific articles published on this topic that enclose.

1.1. Copper Connection with Alzheimer’s Disease: Biochemistry Literature[1]

This literature includes Inorganic and Coordination Chemistry and is mostly focused on the interaction of Aβ and the Aβ precursor protein (APP, encoded by the APP gene) with copper. APP is a copper protein [2]. Consolidate knowledge indicates that the APP/Aβ system is central for AD pathogenesis, and a recent view proposes that the APP/Aβ system is centrally involved in neuronal copper transport at the synapses and in processes of learning and memory [3][4][5]. Loosely bound copper, as a transition metal, actively facilitates oxidative stress via Fenton like and Haber Weiss reactions. These reactions have been demonstrated to result in Aβ oligomer formation and their precipitation within plaques along with lipid peroxidation [6][7][8][9]. Established evidence demonstrated that: APP is a copper protein that binds and reduces copper from Cu(II) to Cu(I) [2], facilitating copper-induced toxicity in cell cultures and oxidative stress through the production of H2O2 [10]; that Aβ and metals are packed together in the brain Aβ plaques [2][11][12]; that Aβ plaques can be dissolved by chelating agents, which sequester the copper [11]. Overload of Cu(II)-Aβ molecules are also probable, particularly at the synapses where both are released [3]: copper ions are released from synaptic vesicles reaching concentrations as high as 15 μmol/L in a form of labile copper, not bound to proteins [13]. These conditions facilitate Cu-Aβ formation. At the same time, cell-associated copper into neurons could be decreased [14].

1.2. Copper Connection with Alzheimer’s Disease: Medicine Literature

Most of these studies focused on the comparison of copper levels in diverse organ tissues or biological matrices (e.g., serum, plasma, cerebrospinal fluid, brain, hair, nails). Most of these findings have been evaluated through meta-analyses that reported excess copper in general circulation [15][16][17] and copper deficiency in the brain [18]. The picture provided supports the evidence that patients with AD fail to maintain a correct metabolic balance and distribution of copper in the body [5]. In line with these findings, a recent meta-analysis has attributed the copper excess found in AD serum to the expansion of the fraction of exchangeable Cu2+ defined as copper not bound to ceruloplasmin (non-ceruloplasmin copper, also referred to as ‘free’ copper) [16]. This serum fraction is composed of copper loosely bound to albumin, α2 macroglobulin, peptides and amino acids and exchanged among them [16]. Non-ceruloplasmin copper has been already identified as a marker of Wilson disease, a rare inborn error of copper metabolism and a paradigm of non-ceruloplasmin copper toxicosis and accumulation [5]. Overall, existing meta-analyses in AD provided results of decreased levels of copper in the brain [18], along with a non-ceruloplasmin copper increase in serum/plasma [15][16][17][19][20], that accounts for copper excess in the bloodstream [21], in line with a number of clinical studies (Table 1).
Table 1. Clinical studies analyzing the copper and ATP7B link to Alzheimer’s disease risk and the association with the subjects’ clinical status.
  Subjects Risk (OR 1, RR 2, HR 3) CI 4 95% p Value
Serum Copper and Risk for Alzheimer’s Disease        
Copper level was higher in subjects with AD than in control subjects and correlated with poor neuropsychological performance and medial temporal lobe atrophy [22] 76 AD vs. 79 healthy subjects 1.8 1.36–2.43 p < 0.05
Copper level was higher in subjects with AD than in patients with vascular dementia subjects (VaD) [23] 48 AD vs. 20 VaD 2.06 1.28–3.31 p < 0.003
Non-ceruloplasmin copper was higher in AD than in healthy controls and VaD and correlated with poor neuropsychological performance [24] 47 AD vs. 44 healthy subjects and 24 VaD subjects     p < 0.001
Non-ceruloplasmin copper was higher in AD than in healthy controls; Cerebrospinal (CSF) β-amyloid and H-Tau correlated with serum non-ceruloplasmin copper; copper in the CSF was partially dependent on the serum Non-ceruloplasmin copper (t = 2.2, p = 0.04). Mini-Mental State Examination (MMSE) and verbal memory scores correlated positively with β-amyloid (r = 0.46, p = 0.002) and inversely with nonceruloplasmin-Cu (= 0.45, p = 0.003) [25] 28 AD vs. 25 healthy subjects     p < 0.001
Non-ceruloplasmin copper predicted the annual change in MMSE; when the annual change in MMSE was divided into <3 or ≥3 points, Non-ceruloplasmin copper was the only predictor of a more severe decline [26] 81 AD subjects, 1 year longitudinal study 1.23 1.03–1.47 p < 0.022
Non-ceruloplasmin copper was higher in MCI than in healthy subjects [27] 83 MCI subjects, 100 healthy subjects 1.22 1.05–1.41 p < 0.01
Copper level showed a significant increase in the serum of AD and MCI compared to control (p = 0.038) [28] 36 AD, 18 MCI vs. 25 healthy subjects     p < 0.05
Non-ceruloplasmin copper increased the risk of having AD; when combined in an algorithm with sex, APOE, Cp/Tf, TAS, the ability to discriminate AD patients vs. controls was high (ROC 5, AUC 6 = 0.9) [29] 93 AD, 45 VaD, 48 healthy subjects 3.21 1.53–6.71 p < 0.002
Non-ceruloplasmin copper was a predictor of conversion to AD: MCI subjects with nonceruloplasmin-Cu levels > 1.6 µmol/L had a hazard conversion rate (50% conversion in 4 years) that was ~3 higher than those with values ≤ 1.6 µmol/L (< 20% in 4 years) [30] 131 MCI subjects, 6 years longitudinal study 3.3 1.21–9.24 p = 0.02
Non-ceruloplasmin copper levels higher in MCI and AD with respect to control (p < 0.0001) [31] 44 AD and 36 MCI vs. 28 healthy subjects     p < 0.001
Non-ceruloplasmin copper and Cu:Cp resulted higher in AD and in Wilson disease (WD) than in healthy controls; while nCp-Cu was similar between AD and WD, Cu:Cp was higher in WD. 24 h urinary copper excretion in AD patients (12.05 μg/day) was higher than in healthy controls (4.82 μg/day); 77.8% of the AD patients under D-penicillamine treatment had a 24 h urinary excretion higher than 200 μg/day, suggestive of a failure of copper control [21] 385 AD, 9 WD, 336 healthy subjects     p < 0.0001
Non-ceruloplasmin copper does not change in frontotemporal lobar degeneration (FTLD) [23] 85 FTLD, 55 healthy subjects     p < 0.001
ATP7B Gene Variants and Risk for Alzheimer’s Disease        
Specific genetic variants in the ATP7B gene, namely rs1801243 (OR = 1.52, 95% CI = 1.10–2.09), rs2147363 (OR = 1.58, 95% CI = 1.11–2.25), rs1061472 (OR = 1.73, 95% CI = 1.23–2.43), and rs732774 (OR = 2.31, 95% CI = 1.41–3.77) increased the risk of having AD [32] 285 AD vs. 230 healthy subjects 2.3 1.41–3.77 p < 0.001
Wilson disease-causing variant rs7334118 in linkage disequilibrium with the intronic rs2147363 (associated with AD risk) was detected in two AD patients but in no healthy individuals. However, this Wilson disease mutation did not explain the observed genetic association of rs2147363. Conversely, in silico analyses of rs2147363 functionality highlighted that this variant is located in a binding site of a transcription factor and is associated with regulatory functions [33] 286 AD vs. 283 healthy subjects 1.3 1.06–1.69 p = 0.015
Haplotype TGC in specific genetic variants in the ATP7B gene, namely rs1801243, rs1801249, rs1801244, and rs1801243 was associated with an increased risk of having AD [34] 120 AD vs. 111 healthy subjects 5.16 2.54–10.5 p < 0.001
1 OR, odds ratio; 2 RR, relative risk; 3 HR, hazard ratio; 4 CI, Coefficient Interval; 5 ROC, receiver operating characteristic curves depict the likelihood of a given test to be excellent, good, or worthless. The accuracy of the test depends, in this case, on the probability that a subject randomly selected from AD group has a nonceruloplasmin copper value higher than that of a subject randomly selected from the healthy control group. The accuracy is measured by the 6 AUC (area under the curve) of the ROC curve. An AUC = 1 represents a perfect test, a value of 0.5 represents a worthless test, and values in the 0.7–0.8 range are considered to be fair.
Clinical studies also provided evidence of copper association with the severity of the disease in terms of performance in neuropsychological test batteries [25][35], disease stage [22][27][30][31] and electroencephalography (EEG) brain rhythms alterations, atrophic and cerebrovascular burden [3][36].
In the AD brain, the progressive increase of the labile copper pool is consistent with the parallel presence of an expanded pool of non-ceruloplasmin copper in the blood [25][37]. Copper disturbance in AD can be described by a loss of functional copper from protein-bound pools that reduces energy production and oxidative stress control, and a gain of redox-toxic function that is described by a bigger pool of copper loosely bound to proteins [3]. Non-ceruloplasmin copper increases the susceptibility to AD approximately threefold [29][30] and it is also associated with a higher frequency of specific variants of the ATP7B gene [32][33][34][38][39][40][41][42][43][44][45][46][47][48] (Table 1). The gene variants rs1061472 and rs732774 of ATP7B are single nucleotide polymorphisms (SNPs) that modify properties of ATPase7B protein and are associated with a higher risk of AD and with the presence of a higher fraction of non-ceruloplasmin copper in serum [25][42][45].

1.3. Copper Connection with Alzheimer’s Disease: Neuroscience

Several scientific articles evaluating measurements of electrical activities in cell culture models have been included in this category [4][49]. A bulk of evidence in this category comes from studies in experimental models focused on the investigation of the causative correlation of copper and non-ceruloplasmin copper in AD development and progression (Table 2) [50][51].
Table 2. Experimental models focused on the investigation of the causative correlation of copper and non-ceruloplasmin copper in Alzheimer’s disease (AD) development and progression.
Authors, Year Animal Model Dose and Route Duration Effects
Animal Models of Copper Neurotoxicity Induced by Altered Diet
Sparks and Schreurs, 2003 [52] New Zealand white rabbits 12 mg/L copper in DW 1 + 2% cholesterol − oral 10 weeks Accumulation of Aβ in brain; deficit in complex memory acquisition
Sparks et al., 2006 [53] Beagle dogs 200 mg/L CuSO4 in DW + high fat diet − oral 4 months Extracellular Aβ deposits
Lu et al., 2006 [54] Kumming strain mice 0.21 mg/L copper in DW + 2% cholesterol − oral 8 weeks Cognitive deficits; neuronal apoptosis
Arnal et al., 2013 [55] Wistar rat 3 mg/L copper in tap water + 2% cholesterol − oral 2 months Increased oxidative stress in brain; increased non-ceruloplasmin copper in hippocampus; increased Aβ (1–42)/ Aβ (1–40) in cortex and hippocampus
Arnal et al., 2013 [55] Wistar rat 3 mg/L copper in tap water + 2% cholesterol − oral 8 weeks Slight nut noticeable change in visuo-spatial memory
Yao et al., 2018 [56] Tg2567 mouse 0.1 mg/L copper in drinking water and 2% cholesterol in the food 3 months Significant deposit of Aβ and senile-plaque formation in hippocampus and temporal cortex regions
Abolaji et al., 2020 [57] D. melanogaster flies Cu2+ (1 mM) 7 days reduced survival
Lamtai et al., 2020 [58] Rat CuCl2 (0.25 mg/kg, 0.5 mg/kg and 1 mg/kg) injected intraperitoneally 8 weeks Working memory, spatial learning and memory were significantly impaired in rats treated with Cu at dose of 1 mg/kg
Models of Copper Neurotoxicity in Genetically Compromised Animals
Sparks et al., 2006 [53] Watanable rabbits 0.13 mg/L copper in DW − oral 10 weeks Accumulation of Aβ in superior temporal cortex and hippocampus
Sparks et al., 2006 [53] PS1/APP transgenic mice 0.12 mg/L Cu in DW − oral 6 weeks Deposition of Aβ
Singh et al., 2013 [59] APP sw/0 mice 0.13 mg/L copper in DW − oral 90 days Increase brain Aβ production; increased neuroinflammation; memory impairment; increased Cu levels in brain capillaries and parenchyma
Yu et al., 2014 [60] 3xTg-AD 250 mg/L CuSO4 in drinking water 6 months memory impairment
1 DW, deionized water.
Huat et al. [61], in a recent review, stated that “considering the robust evidence for copper’s essential roles in the brain, it is not surprising that many studies have proposed that an imbalance in its homeostasis is associated with neurodegenerative disorders”.
In a seminal study published in 2003, Sparks and Schreurs demonstrated that in a cholesterol-fed rabbit model of AD, adding trace amounts of 0.12 mg/L copper to distilled drinking water resulted in significantly enhanced cognitive waning. It also exacerbated Aβ plaque deposition to that of control animals [52]. The study by Singh et al. provided a specific emphasis on the causative role that non-ceruloplasmin copper might play in AD onset and progression [59]. Singh et al. [59] studied normal mice (wild type) and a mouse model of AD (AβPP transgenic mice) exposed to 0.13 mg/L of copper sulfate for 90 days levels of copper via drinking water, which doubled plasma concentrations of non-ceruloplasmin copper. This fact caused either a reduction of CSF Aβ clearance across the blood brain barrier in wild-type mice or an identical effect, along with an increase in Aβ production in the transgenic mice. Thus, proposing the concept that non-ceruloplasmin copper is a causative risk factor for AD.
Thus, the relationship between copper and AD has been extensively researched in recent years.
Chronic exposure to copper and its dyshomeostasis has been linked to accelerate cognitive decline and potentially to increase the risk of AD [4][21][62]. However, copper ions due to their redox ability have been considered to be the main potential therapeutic targets in AD, and a considerable number of ligands have been developed in order to modulate the toxicity associated with copper in this context, via disruption of the Aβ-copper interaction [63].

2. Use of Copper in Agriculture

2.1. Copper Used in Plant Disease Management

Copper has been used in agriculture as a fertilizer and in the management of plant diseases. Organic agriculture is very dependent on copper as a fungicide. Several fungicides have copper in their formulation. The first fungicide to be used in all cropping systems worldwide and most famous there is the Bordeaux mixture (25% CuSO4). The Bordeaux mixture and, consequently, copper has been used in agriculture for more than 160 years in the management of plant diseases [64]. Fishel [65] stated that, during the 1850s in the Bordeaux region in France, a vineyard farmer was having trouble with people stealing grapes from his vines. He applied a mixture of copper and lime to part of his vineyards to make the grapes unattractive. The result was that in the plants where the copper-lime mix was applied, there was no plant disease incidence.
Nowadays copper is mostly used to control the following plant diseases: Grape downy mildew, caused by the Plasmopara viticola, which is a highly damaging disease for grapes, particularly in oceanic climates; Apple scab, caused by the Venturia inaequalis; Potato late blight, caused by the Phytophthora infestans, responsible for a severe disease affecting potato production. In tropical regions, there is an occurrence of the Coffee Rust Disease caused by Hemileia vastatri and the cocoa Witches’ Broom Disease, caused by Crinipellis perniciosa [66][67][68].
The Bordeaux mixture is widely used in organic agriculture worldwide since it is considered to have low toxicity for humans and the environment. Also, other fungicides containing copper in the forms of hydroxide, oxychloride, oxide, and octanoate, can be used in Organic Agriculture. However, they need authorization from the certifiers of organic products to minimize the accumulation of copper in the soil [69]. In Brazil, the recommendation follows specific legislation similar to that proposed by FAO [70][71][72].
In Europe, during the 1950s, copper in quantities of 20 to 30 kg ha−1 year−1, and sometimes even more than 80 kg ha−1 year−1, was applied to crops to protect the plants. In Germany, between 2010 and 2015, on average, in organic farming of hops, grapes, potatoes, apples, squash, and pears copper amounting to 3.1, 2.2, 1.5, 1.5, 1.4, and 1.3 kg ha−1 yr−1, respectively, was used. In that country, the application of copper is restricted to 3 kg ha−1 yr−1 (4 kg ha−1 yr−1 for hops) [73]. In 2013, a survey investigating copper use in Germany [74] revealed that the amounts of copper used per hectare in conventional grape (0.8 kg ha−1), hop (1.7 kg ha−1), and potato-farming (0.8 kg ha−1) were well below those used in organic farming for the same crops (2.3, 2.6, and 1.4 kg ha−1, respectively).
The United States Department of Agriculture (USDA) [75] included several copper-based substances in ‘The National List of Allowed and Prohibited Substances’ in organic agriculture in the United States of America (USA). For instance, copper sulfate is as an algicide in aquatic rice systems and used as tadpole shrimp control in aquatic rice production. Its application is limited to one application per field during any 24 months, and application rates are limited to those which do not increase baseline soil test values for copper over a timeframe agreed upon by the producer and the accredited certifying agent. The USA’s legislation indicates that copper-based materials must be used in a manner that minimizes accumulation in the soil and shall not be used as herbicides.
According to Brazilian law [70][71][72] and FAO recommendation [69], the maximum amount of copper to be applied in organic agriculture is 6 kg ha−1 yr−1. According to Motta [76], in Brazil, some certifiers limit the use of the element to 3 kg ha−1 yr−1. On the other hand, in East Africa, 8 kg ha−1 yr−1 is the maximum allowed the annual copper application in areas with organic agriculture [77][78].
Formulation of Bordeaux mixture, for use in fruit trees, contains 2–10 g/L of copper sulfate and the same amount of lime (Ca(OH)2) diluted in water. The application is sprayed from the vegetative phase until the fruit maturation, with intervals of 10 to 15 days between applications [79]. Natural adhesive spreaders, such as sugar (10–15 g) or skim milk (200 mL), can be used for better adherence to plant leaves [76].
For the grapevine, for example, there is no fixed volume of Bordeaux mixture to be used per hectare, which can vary between 150–700 L ha−1. This volume varies according to several factors, such as the type of sprayer, the size of the plants, the distance between rows of plants, the climatic conditions, the disease to be controlled, and the vegetative stage of the plant [80]. Thus, considering that the smallest application volume (150 L ha−1) has the highest copper content (10 g/L), the highest volume (700 L ha−1) and the lowest content (2 g/L), a maximum of 16 applications per year can be performed in Brazil, so that the maximum annual copper dose of 6 kg ha−1 yr−1 is not exceeded, as recommended by FAO [69].

2.2. Copper Accumulation in Soil and Water

In general, the copper ion is very immobile in soil. Therefore, continuous copper spraying results in the accumulation of this element in the topsoil, reaching toxic levels, possibly causing plant stress, decreasing the soil microbiota biodiversity, and reducing soil fertility [81][82][83]. That is the main reason why organic farmers try to minimize copper use [73].
Sacristán and Carbó [84] studied Spanish and Australian agricultural soils cropped with lettuce. They found that soils with higher pH and higher levels of organic matter and clay result in lower copper mobility in-depth, and therefore copper accumulates in the topsoil layers. However, in general, the toxic effect of copper in plants increases as pH values decrease, due to a rise in the copper bioavailability. On the other hand, in a study conducted in an agricultural region of Haining County in southeast China, Wu et al. [85] found that the copper availability ratio and available copper concentration were decreased as a function of decreasing pH in acid soils (pH < 6.5), and increased with increasing pH in alkali soils (pH > 7.5). In Chile, Ávila et al. [86] found that copper toxicity for earthworms was lower in soils with a higher than 3.5% organic matter (OM) content, likely due to the change in bioavailable copper ions. The mitigating effect of OM was exact for soils with up to 500 mg kg−1 of copper.
The copper exists in soils mainly (60%) water soluble, exchangeable and sorbed forms of total copper in the upper part of soil profiles and the percentage decreases with increasing depth [87]. In Australia, total copper content in soil of Victorian vineyards is five to fifty times as high as that found in natural soils. Moreover, copper content in soil decreases with increasing distance from vines [87].
Soil copper concentration of 100 mg kg−1 influences rice growth, and 10% or more of grain yield, straw weight, and root weight were lost [88]. Besides copper use for plant protection, the use of pig slurry can contribute to copper accumulation in the soil. The tillage system determines the distribution of copper in the soil layers and can be used as a tool to avoid accumulation in the topsoil [89].
Copper release into water occurs through soil erosion, industrial discharge, sewage-treatment, and antifouling paints. Thus, erosion of soils that contain soil particles with adsorbed copper can result in increased copper concentrations in rivers and lakes [90]. Certainly, there is generally no contamination of the groundwater table due to copper applications in agriculture. Copper has a low mobility in the soil and its mobility decreases with increasing clay or organic matter content [84].
At present, the main concern is the increase of copper content during the distribution of drinking water, because many pipes and plumbing fixtures contain copper, which can leach into the drinking water [90]. Certainly in the last few years the use of PVC pipes instead of copper pipes has reduced the concentration of copper in the water. However, this is a problem that still persists in old houses that have copper plumbing for heated water, because this water is often used to cook food.

3. Agricultural Use to Copper and Its Link to Alzheimer’s Disease

Shen et al. [91] showed that the prevalence of AD in the regions in Mainland China with the highest soil copper contents (60–80 mg kg−1) reached 2.6 times compared to the regions that had the lowest copper contents (20–40 mg kg−1).
Morris et al. [92] evaluated 3718 Chicago residents with 65 years and older. They verified that high dietary intake of copper in conjunction with a diet high in saturated and trans fats might be associated with accelerated cognitive decline. Brewer [62] proposed that copper bivalent (Cu2+) ingestion is a major new environmental risk factor for AD. This author commented that Cu2+ is mainly abundant in water and food supplement pills and is much more damaging to cognition. The question remains how much and through which pathways copper used in agriculture ends up in the human diet. Copper is applied on the vegetation and only a small part is absorbed by the leaves and fruits and translocated in the plant. Copper reaches the soil where it is immobilized mainly by soil organic matter and clay particles. Plant roots take up copper as well.
The European Food Safety Authority (EFSA) report [93] makes reference to studies claiming that plants never take up more copper then the nutritional amount needed. However, this is in sharp contrast with other studies carried out in the field of phytoremediation, showing that arable and vegetable crops can take up much more copper then needed and allocate this to root, shoot and fruit tissue. By removal of the biomass, sites can be cleaned from heavy metal and copper pollution [94]. When using crops, it is relevant to know in which plant tissues copper accumulates. Tomato fruit and roots were very effective and in this case fruits should not be used for consumption [94]. Another study showed that Amaranthus, Indian Mustard and Sunflower shoot tissue were able to take up two to four times higher copper amounts than the roots, especially in fertilized soils [95]. EFSA experts [93] further conclude that insufficient scientific studies are available to conclude on the amount of copper residues in some key crops like grapes, tomatoes and cucurbits cropped following the Good Agricultural Practices guidelines. Therefore, more research is needed to clarify how much copper in organic food is bivalent (Cu2+).
Hummes et al. [96] evaluated the centenarian vineyard in the Pinto Bandeira municipality, the northeastern region of the state of Rio Grande do Sul, Brazil. The evaluated vines have been sprayed with copper for more than 100 years. Copper in root and leaf tissues reached 123,00 and 6800 mg kg−1, respectively. In grape juice and wine, copper was 9.08 and 0.78 mg L−1, respectively. However, copper levels in grape juice exceeded by 908% the limit established by Brazilian and international norms. On the other hand, Santos et al. [97] verified that the reduction in the copper content during the last stages of the wine cycle is related to its precipitation in the storage tanks. The copper content in the vineyard soils and, consequently, in grape must and wines is related to different factors such as the total amount of copper fungicide applied during the production period, the number of days between the last application and harvest, biological specificity of cultivars during growth, and the varietal characteristics [98].
Copper has a propensity for the accumulation in the root tissues with little upward movement towards shoots, fruits, and seeds [99]. Alexander et al. [100] verified that carrot and pea cultivars exhibited significant differences in the accumulation of copper from contaminated soil. That demonstrates that the utilization of cultivars that accumulate lower copper can yield better food.
Garrido and Botton [101] recommended a seven-day grace period (the period between the last application and the harvest) for spray products using copper in grape plants. When farmers use copper-oxychloride, the grace period is fourteen days for beans, and seven days for potato, eggplant, carrot, papaya, watermelon, peppers, and tomatoes [102]. We suggest that the grace period needs to be researched further because the copper residual contamination is dependent on the copper content in the spraying fungicide solution. Indeed, the new upper limits and recommendations of copper should be indicated in the future, due to its high impact on the soil, ecosystem, and human health.

References

  1. Multhaup, G.; Schlicksupp, A.; Hesse, L.; Beher, D.; Ruppert, T.; Masters, C.L.; Beyreuther, K. The amyloid precursor protein of Alzheimer’s disease in the reduction of copper (II) to copper (I). Science 1996, 271, 1406–1409.
  2. Kepp, K.P.; Squitti, R. Copper imbalance in Alzheimer’s disease: Convergence of the chemistry and the clinic. Coord. Chem. Rev. 2019, 397, 168–187.
  3. Squitti, R.; Malosio, M.L.; Rongioletti, M.C.A.; Tecchio, F. Copper involvement in glutamatergic transmission in physiology and disease as revealed by magnetoencephalography/electroencephalography (MEG/EEG) studies. Aging Clin. Exp. Res. 2019, 9.
  4. Sensi, S.L.; Granzotto, A.; Siotto, M.; Squitti, R. Copper and Zinc Dysregulation in Alzheimer’s Disease. Trends Pharmacol. Sci. 2018, 39, 1049–1063.
  5. Acevedo, K.M.; Hung, Y.H.; Dalziel, A.H.; Li, Q.X.; Laughton, K.; Wikhe, K.; Rembach, A.; Roberts, B.; Masters, C.L.; Bush, A.I.; et al. Copper promotes the trafficking of the amyloid precursor protein. J. Biol. Chem. 2011, 286, 8252–8262.
  6. Atwood, C.S.; Scarpa, R.C.; Huang, X.; Moir, R.D.; Jones, W.D.; Fairlie, D.P.; Tanzi, R.E.; Ashley, I. Bush Characterization of copper interactions with alzheimer amyloid beta peptides: Identification of an attomolar-affinity copper binding site on amyloid beta1-42. J. Neurochem. 2000, 75, 1219–1233.
  7. Huang, X.; Atwood, C.S.; Hartshorn, M.A.; Multhaup, G.; Goldstein, L.E.; Scarpa, R.C.; Cuajungco, M.P.; Gray, D.N.; Lim, J.; Moir, R.D.; et al. The A beta peptide of Alzheimer’s disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999, 38, 7609–7616.
  8. Huang, X.; Cuajungco, M.P.; Atwood, C.S.; Hartshorn, M.A.; Tyndall, J.D.A.; Hanson, G.R.; Stokes, K.C.; Leopold, M.; Multhaup, G.; Goldstein, L.E.; et al. Cu(II) potentiation of Alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J. Biol. Chem. 1999, 274, 37111–37116.
  9. Palmer, C.; Menzies, S.L.; Roberts, R.L.; Pavlick, G.; Connor, J.R. Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat. J. Neurosci. Res. 1999, 56, 60–71.
  10. Cherny, R.A.; Legg, J.T.; McLean, C.A.; Fairlie, D.P.; Huang, X.; Atwood, C.S.; Beyreuther, K.; Tanzi, R.E.; Masters, C.L.; Bush, A.I. Aqueous dissolution of Alzheimer’s disease Abeta amyloid deposits by biometal depletion. J. Biol. Chem. 1999, 274, 23223–23228.
  11. Cherny, R.A.; Atwood, C.S.; Xilinas, M.E.; Gray, D.N.; Jones, W.D.; McLean, C.A.; Barnham, K.J.; Volitakis, I.; Fraser, F.W.; Kim, Y.; et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer’s disease transgenic mice. Neuron 2001, 30, 665–676.
  12. Atwood, C.S.; Moir, R.D.; Huang, X.; Scarpa, R.C.; Bacarra, N.M.; Romano, D.M.; Hartshorn, M.A.; Tanzi, R.E.; Bush, A.I. Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 1998, 273, 12817–12826.
  13. Barnham, K.J.; Bush, A.I. Metals in Alzheimer’s and Parkinson’s diseases. Curr. Opin. Chem. Biol. 2008, 12, 222–228.
  14. Bucossi, S.; Ventriglia, M.; Panetta, V.; Salustri, C.; Pasqualetti, P.; Mariani, S.; Siotto, M.; Rossini, P.M.; Squitti, R. Copper in Alzheimer’s disease: A meta-analysis of serum, plasma, and cerebrospinal fluid studies. J. Alzheimer’s Dis. 2011, 24, 175–185.
  15. Squitti, R.; Simonelli, I.; Ventriglia, M.; Siotto, M.; Pasqualetti, P.; Rembach, A.; Doecke, J.; Bush, A.I. Meta-analysis of serum non-ceruloplasmin copper in Alzheimer’s disease. J. Alzheimer’s Dis. 2014, 38, 809–822.
  16. Li, D.D.; Zhang, W.; Wang, Z.Y.; Zhao, P. Serum Copper, Zinc, and Iron Levels in Patients with Alzheimer’s Disease: A Meta-Analysis of Case-Control Studies. Front. Aging Neurosci. 2017, 9, 300.
  17. Schrag, M.; Mueller, C.; Oyoyo, U.; Smith, M.A.; Kirsch, W.M. Iron, zinc and copper in the Alzheimer’s disease brain: A quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Prog. Neurobiol. 2011, 94, 296–306.
  18. Ventriglia, M.; Bucossi, S.; Panetta, V.; Squitti, R. Copper in Alzheimer’s disease: A meta-analysis of serum, plasma, and cerebrospinal fluid studies. J. Alzheimer’s Dis. 2012, 30, 981–984.
  19. Wang, Z.X.; Tan, L.; Wang, H.F.; Ma, J.; Liu, J.; Tan, M.S.; Sun, J.H.; Zhu, X.C.; Jiang, T.; Yu, J.T. Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer’s Disease: A Replication Study and Meta-Analyses. J. Alzheimer’s Dis. 2015, 47, 565–581.
  20. Squitti, R.; Ghidoni, R.; Simonelli, I.; Ivanova, I.D.; Colabufo, N.A.; Zuin, M.; Benussi, L.; Binetti, G.; Cassetta, E.; Rongioletti, M.; et al. Copper dyshomeostasis in Wilson disease and Alzheimer’s disease as shown by serum and urine copper indicators. J. Trace Elem. Med. Biol. 2018, 45, 181–188.
  21. Squitti, R.; Lupoi, D.; Pasqualetti, P.; Dal Forno, G.; Vernieri, F.; Chiovenda, P.; Rossi, L.; Cortesi, M.; Cassetta, E.; Rossini, P.M. Elevation of serum copper levels in Alzheimer’s disease. Neurology 2002, 59, 1153–1161.
  22. Squitti, R.; Fostinelli, S.; Siotto, M.; Ferrari, C.; Binetti, G.; Benussi, L.; Rongioletti, M.; Ghidoni, R. Serum Copper is not Altered in Frontotemporal Lobar Degeneration. J. Alzheimer’s Dis. 2018, 63, 1427–1432.
  23. Squitti, R.; Pasqualetti, P.; Dal Forno, G.; Moffa, F.; Cassetta, E.; Lupoi, D.; Vernieri, F.; Rossi, L.; Baldassini, M.; Rossini, P.M. Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology 2005, 64, 1040–1046.
  24. Squitti, R.; Barbati, G.; Rossi, L.; Ventriglia, M.; Dal Forno, G.; Cesaretti, S.; Moffa, F.; Caridi, I.; Cassetta, E.; Pasqualetti, P.; et al. Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau. Neurology 2006, 67, 76–82.
  25. Squitti, R.; Bressi, F.; Pasqualetti, P.; Bonomini, C.; Ghidoni, R.; Binetti, G.; Cassetta, E.; Moffa, F.; Ventriglia, M.; Vernieri, F.; et al. Longitudinal prognostic value of serum “free” copper in patients with Alzheimer disease. Neurology 2009, 72, 50–55.
  26. Squitti, R.; Ghidoni, R.; Scrascia, F.; Benussi, L.; Panetta, V.; Pasqualetti, P.; Moffa, F.; Bernardini, S.; Ventriglia, M.; Binetti, G.; et al. Free copper distinguishes mild cognitive impairment subjects from healthy elderly individuals. J. Alzheimer’s Dis. 2011, 23, 239–248.
  27. Lopez, N.; Tormo, C.; De Blas, I.; Llinares, I.; Alom, J. Oxidative stress in Alzheimer’s disease and mild cognitive impairment with high sensitivity and specificity. J. Alzheimer’s Dis. 2013, 33, 823–829.
  28. Squitti, R.; Pasqualetti, P.; Polimanti, R.; Salustri, C.; Moffa, F.; Cassetta, E.; Lupoi, D.; Ventriglia, M.; Cortesi, M.; Siotto, M.; et al. Metal-score as a potential non-invasive diagnostic test for Alzheimer’s disease. Curr. Alzheimer Res. 2013, 10, 191–198.
  29. Squitti, R.; Ghidoni, R.; Siotto, M.; Ventriglia, M.; Benussi, L.; Paterlini, A.; Magri, M.; Binetti, G.; Cassetta, E.; Caprara, D.; et al. Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease. Ann. Neurol. 2014, 75, 574–580.
  30. Rozzini, L.; Lanfranchi, F.; Pilotto, A.; Catalani, S.; Gilberti, M.E.; Paganelli, M.; Apostoli, P.; Padovani, A. Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study. J. Alzheimer’s Dis. 2018, 61, 907–912.
  31. Squitti, R.; Polimanti, R.; Bucossi, S.; Ventriglia, M.; Mariani, S.; Manfellotto, D.; Vernieri, F.; Cassetta, E.; Ursini, F.; Rossini, P.M. Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer’s disease. Rejuvenation Res. 2013, 16, 3–10.
  32. Bucossi, S.; Polimanti, R.; Ventriglia, M.; Mariani, S.; Siotto, M.; Ursini, F.; Trotta, L.; Scrascia, F.; Callea, A.; Vernieri, F.; et al. Intronic rs2147363 variant in ATP7B transcription factor-binding site associated with Alzheimer’s disease. J. Alzheimer’s Dis. 2013, 37, 453–459.
  33. Liu, H.P.; Lin, W.Y.; Wang, W.F.; Tsai, C.H.; Wu, W.C.; Chiou, M.T.; Shen, C.P.; Wu, B.T.; Tsai, F.J. Genetic variability in copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with Alzheimer’s disease in a Chinese population. J. Biol. Regul. Homeost. Agents 2013, 27, 319–327.
  34. Hoogenraad, T. Diagnosis. In Wilson’s disease, 2nd ed.; Intermed Medical Publishers: Amsterdam, The Netherlands, 2001; pp. 109–137.
  35. Squitti, R.; Simonelli, I.; Cassetta, E.; Lupoi, D.; Rongioletti, M.; Ventriglia, M.; Siotto, M. Patients with Increased Non-Ceruloplasmin Copper Appear a Distinct Sub-Group of Alzheimer’s Disease: A Neuroimaging Study. Curr. Alzheimer Res. 2017, 14, 1318–1326.
  36. James, S.A.; Volitakis, I.; Adlard, P.A.; Duce, J.A.; Masters, C.L.; Cherny, R.A.; Bush, A.I. Elevated labile Cu is associated with oxidative pathology in Alzheimer’s Disease. Free Radic. Biol. Med. 2012, 52, 298–302.
  37. Bucossi, S.; Mariani, S.; Ventriglia, M.; Polimanti, R.; Gennarelli, M.; Bonvicini, C.; Pasqualetti, P.; Scrascia, F.; Migliore, S.; Vernieri, F.; et al. Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer’s Disease. Int. J. Alzheimer’s Dis. 2011, 2011, 973692.
  38. Bucossi, S.; Polimanti, R.; Mariani, S.; Ventriglia, M.; Bonvicini, C.; Migliore, S.; Manfellotto, D.; Salustri, C.; Vernieri, F.; Rossini, P.M.; et al. Association of K832R and R952K SNPs of Wilson’s disease gene with Alzheimer’s disease. J. Alzheimer’s Dis. 2012, 29, 913–919.
  39. McCann, C.J.; Jayakanthan, S.; Siotto, M.; Yang, N.; Osipova, M.; Squitti, R.; Lutsenko, S. Single nucleotide polymorphisms in the human ATP7B gene modify the properties of the ATP7B protein. Metallomics 2019, 11, 1128–1139.
  40. Mercer, S.W.; Wang, J.; Burke, R. In Vivo Modeling of the Pathogenic Effect of Copper Transporter Mutations That Cause Menkes and Wilson Diseases, Motor Neuropathy, and Susceptibility to Alzheimer’s Disease. J. Biol. Chem. 2017, 292, 4113–4122.
  41. Salustri, C.; Siotto, M.; Bucossi, S.; Squitti, R. Metals Involvement in Alzheimer’s Disease—A Patho-Genetic View. In Alzheimer’s Disease—Challenges for the Future; Zerr, P.I., Ed.; InTech: London, UK, 2015; Volume 4.
  42. Squitti, R.; Polimanti, R. Copper hypothesis in the missing hereditability of sporadic Alzheimer’s disease: ATP7B gene as potential harbor of rare variants. J. Alzheimer’s Dis. 2012, 29, 493–501.
  43. Squitti, R.; Polimanti, R. Copper phenotype in Alzheimer’s disease: Dissecting the pathway. Am. J. Neurodegener. Dis. 2013, 2, 46–56.
  44. Squitti, R.; Polimanti, R.; Siotto, M.; Bucossi, S.; Ventriglia, M.; Mariani, S.; Vernieri, F.; Scrascia, F.; Trotta, L.; Rossini, P.M. ATP7B variants as modulators of copper dyshomeostasis in Alzheimer’s disease. Neuromolecular Med. 2013, 15, 515–522.
  45. Squitti, R.; Siotto, M.; Bucossi, S.; Polimanti, R. In silico investigation of the ATP7B gene: Insights from functional prediction of non-synonymous substitution to protein structure. Biometals 2014, 27, 53–64.
  46. Squitti, R.; Siotto, M.; Ivanova, I.; Rongioletti, M. ATP7B and Alzheimer disease. In Clinical and Translational Perspectives on WILSON DISEASE; Kerkar, N., Roberts, E.A., Eds.; Elsevier B.V.: Amsterdam, The Netherlands, 2019; Volume 42, pp. 427–436.
  47. Squitti, R.; Ventriglia, M.; Gennarelli, M.; Colabufo, N.A.; El Idrissi, I.G.; Bucossi, S.; Mariani, S.; Rongioletti, M.; Zanetti, O.; Congiu, C.; et al. Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer’s Disease: A Genetic Study of ATP7B Frequency. Mol. Neurobiol. 2017, 54, 671–681.
  48. Telianidis, J.; Hung, Y.H.; Materia, S.; Fontaine, S.L. Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis. Front. Aging Neurosci. 2013, 5, 44.
  49. Pal, A.; Siotto, M.; Prasad, R.; Squitti, R. Towards a unified vision of copper involvement in Alzheimer’s disease: A review connecting basic, experimental, and clinical research. J. Alzheimer’s Dis. 2015, 44, 343–354.
  50. Squitti, R.; Tecchio, F.; Ventriglia, M. The Role of Copper in Human Diet and Risk of Dementia. Curr. Nutr. Rep. 2015, 4, 114–125.
  51. Sparks, D.L.; Schreurs, B.G. Trace amounts of copper in water induce-amyloid plaques and learning deficits in a rabbit model of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 2003, 100, 11065–11069.
  52. Sparks, D.L.; Friedland, R.; Petanceska, S.; Schreurs, B.G.; Shi, J.; Perry, G.; Smith, M.A.; Sharma, A.; Derosa, S.; Ziolkowski, C.; et al. Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology. J. Nutr. Health Aging. 2006, 10, 247–254.
  53. Lu, J.; Zheng, Y.L.; Wu, D.M.; Sun, D.X.; Shan, Q.; Fan, S.H. Trace amounts of copper induce neurotoxicity in the cholesterol-fed mice through apoptosis. FEBS Lett. 2006, 580, 6730–6740.
  54. Arnal, N.; Castillo, O.; de Alaniz, M.J.; Marra, C.A. Effects of Copper and/or Cholesterol Overload on Mitochondrial Function in a Rat Model of Incipient Neurodegeneration. Int. J. Alzheimer’s Dis. 2013, 2013, 645379.
  55. Yao, D.; Jing, T.; Niu, L.; Huang, X.; Wang, Y.; Deng, X.; Wang, M. Amyloidogenesis induced by diet cholesterol and copper in a model mouse for Alzheimer’s disease and protection effects of zinc and fluvastatin. Brain Res. Bull. 2018, 143, 1–8.
  56. Abolaji, A.O.; Fasae, K.D.; Iwezor, C.E.; Aschner, M.; Farombi, E.O. Curcumin attenuates copper-induced oxidative stress and neurotoxicity in Drosophila melanogaster. Toxicol. Rep. 2020, 7, 261–268.
  57. Lamtai, M.; Zghari, O.; Ouakki, S.; Marmouzi, I.; Mesfioui, A.; EI Hessni, A.; Ouichou, A. Chronic copper exposure leads to hippocampus oxidative stress and impaired learning and memory in male and female rats. Toxicol. Res. 2020.
  58. Singh, I.; Sagare, A.P.; Coma, M.; Perlmutter, D.; Gelein, R.; Bell, R.D.; Deane, R.J.; Zhong, E.; Parisi, M.; Ciszewski, J.; et al. Low levels of copper disrupt brain amyloid-beta homeostasis by altering its production and clearance. Proc. Natl. Acad. Sci. USA 2013, 110, 14771–14776.
  59. Yu, J.; Luo, X.; Xu, H.; Ma, Q.; Yuan, J.; Li, X.; Chang, R.C.; Qu, Z.; Huang, X.; Zhuang, Z.; et al. Identification of the Key Molecules Involved in Chronic Copper Exposure-Aggravated Memory Impairment in Transgenic Mice of Alzheimer’s Disease Using Proteomic Analysis. J. Alzheimer’s Dis. 2015, 44, 455–469.
  60. Huat, T.J.; Camats-Perna, J.E.; Newcombe, A.; Valmas, N.; Kitazawa, M.; Medeiros, R. Metal Toxicity Links to Alzheimer’s Disease and Neuroinflammation. J. Mol. Biol. 2019, 431, 1843–1868.
  61. Brewer, G.J. Copper-2 Hypothesis for Causation of the Current Alzheimer’s Disease Epidemic Together With Dietary Changes That Enhance the Epidemic. Chem. Res. Toxicol. 2017, 30, 763–768.
  62. Esmieu, C.; Guettas, D.; Conte-Daban, A.; Sabater, L.; Faller, P.; Hureau, C. Copper-Targeting Approaches in Alzheimer’s Disease: How To Improve the Fallouts Obtained From in Vitro Studies. Inorg. Chem. 2019, 58, 13509–13527.
  63. Lamichhane, J.R.; Osdaghi, E.; Behlau, F.; Köhl, J.; Jones, J.B.; Aubertot, J.N. Thirteen decades of antimicrobial copper compounds applied in agriculture. A review. Agron. Sustain. Dev. 2018, 38, 1–18.
  64. Fishel, F.M. Pest Management and Pesticides: A Historical Perspective. Available online: (accessed on 24 April 2020).
  65. Lara, W.H.; Toledo, M.; Takahashi, M.Y. Teores de cobre em café torrado e moído e em café bebida. Rev. Inst. Adolfo Lutz 1975, 35, 17–22.
  66. Almeida, O.C.; Almeida, L.C.C.; Bezerra, J.L. Estudo de fungicidas à base de cobre no controle da vassourade-bruxa do cacaueiro no sudeste da Bahia. Agrotrópica 2002, 14, 97–100.
  67. Can Organic Agriculture Give Up Copper As a Crop Protection Product? Available online: (accessed on 24 April 2020).
  68. FAO—Guidelines for the Production, Processing, Labelling and Marketing of Organically Produced Foods1. Available online: (accessed on 24 April 2020).
  69. Instrução Normativa Interministerial Nº 28 de 08 de Junho de 2011 (Produção de Organismos Aquáticos).pdf—Português (Brasil). Available online: (accessed on 27 April 2020).
  70. Ministério da Agricultura, Pecuária e Abastecimento. Available online: (accessed on 24 January 2020).
  71. Ministério da Agricultura, Pecuária e Abastecimento. Available online: (accessed on 24 January 2020).
  72. ifoam_eu_copper_minimisation_in_organic_farming_may2018_0.pdf. Available online: (accessed on 30 January 2020).
  73. Kuhne, S.; Roßberg, D.; Rohrig, P.; Mering, F.; Weihrauch, F.; Kanthak, S.; Kienzle, J.; Patzwahl, W.; Reiners, E.; Gitzel, J. The Use of Copper Pesticides in Germany and the Search for Minimization and Replacement Strategies. Org. Farming 2017, 3, 66–75.
  74. USDA—United States Department of Agriculture. Available online: (accessed on 30 January 2020).
  75. Calda Bordalesa: Utilidades e Preparo. Ministério da Agricultura. Available online: (accessed on 20 January 2020).
  76. EAOPS—East African Organic Products Standard. Available online: (accessed on 20 January 2020).
  77. EAC. Aid for Trade Case Story: The East African Organic Products Standard Submission by the United Nations Environment Programme. Available online: (accessed on 24 January 2020).
  78. Aplicação de calda bordalesa em frutíferas. Available online: (accessed on 24 January 2020).
  79. Sistema de produção de uva de mesa do norte de Minas Gerais. Available online: (accessed on 12 January 2020).
  80. Rusjan, D.; Strlič, M.; Pucko, D.; Korošec-Koruza, Z. Copper accumulation regarding the soil characteristics in Sub-Mediterranean vineyards of Slovenia. Geoderma 2007, 141, 111–118.
  81. Calviño, D.F.; Nóvoa-Muñoz, J.C.; Díaz-Raviña, M.; Arias-Estévez, M. Copper accumulation and fractionation in vineyard soils from temperate humid zone (NW Iberian Peninsula). Geoderma 2009, 153, 119–129.
  82. Tóth, G.; Hermann, T.; Silva, M.R. Heavy metals in agricultural soils of the European Union with implications for food safety. Environ. Int. 2016, 88, 299–309.
  83. Sacristán, D.; Carbó, E. Copper Contamination in Mediterranean Agricultural Soils: Soil Quality Standards and Adequate Soil Management Practices for Horticultural Crops. In Soil Contamination—Current Consequences and Further Solutions; Larramendy, M.L., Soloneski, S., Eds.; InTech: London, UK, 2016; Volume 4.
  84. Wu, C.; Luo, Y.; Zhang, L. Variability of copper availability in paddy fields in relation to selected soil properties in southeast China. Geoderma 2010, 156, 200–206.
  85. Ávila, G.; Gaete, H.; Sauvé, S.; Neaman, A. Organic matter reduces copper toxicity for the earthworm Eisenia fetida in soils from mining areas in Central Chile. Chil. J. Agric. Res. 2009, 69, 252–259.
  86. Pietrzak, U.; McPhail, D.C. Copper accumulation, distribution and fractionation in vineyard soils of Victoria, Australia. Geoderma 2004, 122, 151–166.
  87. Xu, J.; Yang, L.; Wang, Z.; Dong, G.; Huang, J.; Wang, Y. Toxicity of copper on rice growth and accumulation of copper in rice grain in copper contaminated soil. Chemosphere 2006, 62, 602–607.
  88. Mallmann, F.J.K.; Rheinheimer, D.S.; Ceretta, C.A.; Cella, C.; Minella, J.P.G.; Guma, R.L.; Filipovi, V.; Oort, F.; Šimunek, J. Soil tillage to reduce surface metal contamination—Model development and simulations of zinc and copper content profiles in a pig slurry-amended soil. Agric. Ecosyst. Environ. 2014, 196, 59–68.
  89. National Research Council (US) Committee on Copper in Drinking Water. Copper in Drinking Water. Available online: (accessed on 12 January 2020).
  90. Shen, X.L.; Yu, J.H.; Zhang, D.F.; Xie, J.X.; Jiang, H. Positive relationship between mortality from Alzheimer’s disease and soil metal concentration in mainland China. J. Alzheimer’s Dis. 2014, 42, 893–900.
  91. Morris, M.C.; Evans, D.A.; Tangney, C.C.; Bienias, J.L.; Schneider, J.A.; Wilson, R.S.; Scherr, P.A. Dietary Copper and High Saturated and trans Fat Intakes Associated With Cognitive Decline. Arch. Neurol. 2006, 63, 1085–1088.
  92. EFSA (European Food Safety Authority) Peer review of the pesticide risk assessment of the active substance copper compounds. EFSA J. 2018, 16, 5152.
  93. Napoli, M.; Cecchi, S.; Grassi, C.; Baldi, A.; Zanchi, C.A.; Orlandini, S. Phytoextraction of copper from a contaminated soil using arable and vegetable crops. Chemosphere 2019, 219, 122–129.
  94. Rahman, M.M.; Azirun, S.M.; Boyce, A.N. Enhanced Accumulation of Copper and Lead in Amaranth (Amaranthus paniculatus), Indian Mustard (Brassica juncea) and Sunflower (Helianthus annuus). PLoS ONE 2013, 8, e62941.
  95. Hummes, A.P.; Bortoluzzi, E.C.; Tonini, V.; Silva, L.; Petry, C. Transfer of Copper and Zinc from Soil to Grapevine-Derived Products in Young and Centenarian Vineyards. Water Air Soil Pollut. 2019, 230, 150–161.
  96. Santos, C.E.; Debastiani, R.; Souza, V.S.; Peretti, D.E.; Jobim, P.F.; Yoneama, M.L.; Amaral, L.; Dias, J.F. The influence of the winemaking process on the elemental composition of the Marselan red wine. J. Sci. Food Agric. 2019, 99, 4642–4650.
  97. Donici, A.C.; Bunea, I.; Călugăr, A.; Harsan, E.; Bora, F.D. Investigation of the Copper Content in Vineyard Soil, Grape, Must and Wine in the Main Vineyards of Romania: A Preliminary Study. Bull. UASVM Hortic. 2019, 76, 31–46.
  98. Rehman, M.; Liu, L.; Wang, Q.; Saleem, M.H.; Bashir, S.; Ullah, S.; Peng, D. Copper environmental toxicology, recent advances, and future outlook: A review. Environ. Sci. Pollut. Res. 2019, 26, 18003–18016.
  99. Alexander, P.D.; Alloway, B.J.; Dourado, A.M. Genotypic variations in the accumulation of Cd, Cu, Pb and Zn exhibited by six commonly grown vegetables. Environ. Pollut. 2006, 144, 736–745.
  100. Garrido, L.R.; Botton, M. Recomendações Técnicas para o Manejo das Pragas e Doenças Fúngicas da Videira na Região Sul do Brasil. In Circula Téchnica; Empresa Brasileira de Pesquisa Agropecuária: Bento Gonçalves, RS, Brasil, 2015; Volume 117, pp. 3–23.
  101. 1516729946. Available online: (accessed on 24 January 2020).
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Neurosciences
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Rosanna Squitti
View Times: 619
Revisions: 2 times (View History)
Update Date: 22 Jun 2021
Table of Contents
    1000/1000
    Hot Most Recent
    ScholarVision Creations
    Feedback